| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > Using Effective Public Relations to Attract Investors |
|
Advice You - Using Effective Public Relations to Attract Investors
For companies looking to take their enterprise to the next step, the search for
inve According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product stors and/or satisfy venture capitalists requires an in depth understanding of
the p ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in actice of investor relations. Here are a few considerations to put in place so that p lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. tential and current investors
are attracted to the natural value of your company: < here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe l>
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro
investors, any savvy investor will be on the look out for the newest development or ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
innovation that could catch on like what iTunes did for Apple. The forums you
moni easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi or should be archived, so the reach to the investment community is extended
long bey nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nd the date of any event or product launch you hold.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ specific industry sector and present in-depth
content from keynote speakers and cor ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi orate executives. In an environment
saturated with information from the media you ca ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a n grow your shareholder base by
communicating your message directly to a live audien dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e of investors by making a
CEO's speech available on the company website.
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin relationships with reputable stockbrokers, venture capital and investment banking firm tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . In most major cities, angel investor associations are also an excellent
group to r t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ach out towards.
ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nd designed.
The Corporate Profile should become an integral part of your overall In y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products estor
Information Package.
Solid Investor Relations is no different that int . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de lligently applied Public Relations. It's
all about the story. Tell the great story elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip of your company, do it professionally, and
target your message to the right audience tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Bad Credit Loan Secrets Most Lenders Don't Want You to Know Organizational Change: Mission Impossible? Marketing: The Value of Your Own Experience
|